Published in Zh Nevrol Psikhiatr Im S S Korsakova on January 01, 1997
Neuroprotective effects of glycine for therapy of acute ischaemic stroke. Cerebrovasc Dis (2000) 0.97
Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Neuroscience (2000) 0.96
Expression of NMDA neuroreceptors in experimental ischemia. Biochemistry (Mosc) (2003) 0.80
Mechanisms of the influences of the central administration of substance P on ethanol consumption in chronically alcoholic rats. Neurosci Behav Physiol (2003) 0.79
[Physiological mechanisms of the effectiveness of bilateral stereotactic cingulotomy in treatment of strong psychological dependence in drug addiction]. Fiziol Cheloveka (2003) 0.78
The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy. J Neurol Sci (1997) 0.78
[Effect of substance P on ethanol consumption in subchronically alcoholized rats in the limited scheduled access paradigm]. Zh Vyssh Nerv Deiat Im I P Pavlova (2001) 0.77
[Pathology of the anterior cingulate cortex in obsessive compulsive disorder]. Fiziol Cheloveka (2013) 0.77
The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis. Neurosci Behav Physiol (2004) 0.77
[Role and place of biochemical markers in diagnosis of cerebral ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2010) 0.77
[The influence of substance P central administration on ethanol intake in rats chronically exposed to alcohol]. Ross Fiziol Zh Im I M Sechenova (2002) 0.77
[The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.77
[Functional biomarkers in the diagnostics of mental disorders: cognitive event-related potentials]. Fiziol Cheloveka (2013) 0.77
[The experience in surgical treatment of Gilles de la Tourette's syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.76
[Hemorrhagic and neurological complications in aplastic anemia patients]. Ter Arkh (1996) 0.76
[The systematization of epilepsy remissions]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75
[Neurophysiologic correlates of the altered state of consciousness during hypnosis]. Fiziol Cheloveka (1991) 0.75
[The desynchronization and synchronization of the adolescent EEG evoked by stimuli triggering or suppressing a sensorimotor reaction. II. Their characteristics in the attention-deficit and hyperactivity syndrome]. Fiziol Cheloveka (2000) 0.75
[An analysis of the importance of low-molecular peptides in regulating human motor functions in diseases of the central nervous system]. Fiziol Zh SSSR Im I M Sechenova (1989) 0.75
Growth-stimulating phase of macrophage response to activation: the phenomenon and its implications for tumour growth and immunotherapy. J Cancer Res Clin Oncol (1992) 0.75
[A clinico-pharmacological basis for optimizing the treatment of therapy-resistant forms of epilepsy]. Eksp Klin Farmakol (1997) 0.75
[Effect of amniotic fluid on cell differentiation in neural tissue culture in pathologic embryo development (anencephaly)]. Biull Eksp Biol Med (1996) 0.75
[Search for and study of cDNA coding synthesis of glutamate receptors of the human brain]. Dokl Akad Nauk SSSR (1988) 0.75
[Adaptive biocontrol in the system of treating epilepsy patients]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75
[Molecular organization of glutamate-sensitive, chemoexcitatory membranes of nerve cells. Physico-chemical characteristics of the glutamate-binding synaptic membrane proteins of the rat cerebral cortex]. Biokhimiia (1984) 0.75
[Effect of the neuropeptide substance P on the activity of the brain dopaminergic system in experimental parkinsonism]. Fiziol Cheloveka (1995) 0.75
[The sites of high affinity binding of L-[3H]glutamic acid in human platelets. A new type of platelet receptor?]. Biokhimiia (1988) 0.75
[Clinical and physiologic characterization of therapeutic effects of intrathecal infusion of autologous blood serum in Parkinson's disease]. Fiziol Cheloveka (1999) 0.75
[Investigation of efficacy of convulex-retard in epilepsy treatment]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.75
[Possible role of calcium in regulating the RNA-synthesizing activity of brain tissue cell nuclei]. Biull Eksp Biol Med (1981) 0.75
[Molecular organization of glutamate-sensitive chemoexcitable membranes of nerve cells. Function of glutamate-binding proteins of the central nervous system when incorporated into liposomes]. Biokhimiia (1985) 0.75
[The use of the antiepileptic drug trileptal in the clinical practice]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.75
Analysis of L-[3H]-glutamate radioligand binding to plasma membranes of the ampullae of Lorenzini of skates. Neuroreport (1993) 0.75
[3H-1-glutamate binding with the synaptic membranes isolated from the cerebral cortex and hippocampus of Krushinskiĭ-Molodkina strain rats]. Biull Eksp Biol Med (1982) 0.75
Receptor binding of glutamate in the striatum of rats differing in learning capacity. Neurosci Behav Physiol (1995) 0.75
[Fluctuations in catecholamine levels in blood plasma in the bicycle ergometry test in patients with ischemic heart disease]. Fiziol Cheloveka (1997) 0.75
[Convulex and its place in epilepsy treatment with original valproates]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75
[Pathogenic role of the endogenous convulsant kynurenine in the mechanisms of development of epileptic attacks in alcoholics]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75
[Changes in rabbit skeletal muscle histone concentration at different periods following denervation]. Biokhimiia (1976) 0.75
[Role of calcium in realization of nervous control during RNA synthesis in skeletal muscles]. Biokhimiia (1979) 0.75
[Modern aspects of the rehabilitation of patients with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.75
[Autoantibodies to NMDA-type glutamate receptors in the blood of patients with acute ischemic and hemorrhagic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75
[Glutamate receptors in the human brain visualized using monoclonal antibodies]. Dokl Akad Nauk SSSR (1989) 0.75
[Hexamidine content of the blood plasma and cerebrospinal fluid in patients with epilepsy]. Zh Nevropatol Psikhiatr Im S S Korsakova (1988) 0.75
[Determination of antibodies to opiate receptors by latex agglutination and immunoenzyme analysis]. Biomed Khim (2003) 0.75
[The effect of monoclonal antibodies on the sensomotor neuron connection of isolated frog spinal cord]. Dokl Akad Nauk SSSR (1991) 0.75
[The diagnosis of epilepsy by using blood analysis for the content of autoantibodies to glutamate neuroreceptors]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.75
[Effect of etimizol on the RNA synthesizing activity of brain cell nuclei during the learning process in rats]. Biull Eksp Biol Med (1981) 0.75
[Glutamate receptor binding in the striatum of rats differing in the ability to learn]. Fiziol Zh Im I M Sechenova (1994) 0.75
[Topamax in the treatment of epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.75
[Low molecular mRNA from polyribosomes of normal and denervated rabbit muscles]. Dokl Akad Nauk SSSR (1976) 0.75
[Action of doubled derivatives of glutamic acid on mollusk neurons]. Neirofiziologiia (1988) 0.75
[The current aspects of the social and biological adaptation of epilepsy patients in Russia]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.75
[Isolation and partial purification of the endogenous inhibitor of receptor binding of 3H-L-glutamate]. Biull Eksp Biol Med (1986) 0.75
[Significance of the level of auto-antibodies for the NMDA type glutamate receptors in diagnosis of chronic cerebral circulation disorders]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[Topamax in the system of drug therapy of epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (2004) 0.75
[Use of low-molecular fractions of blood plasma in movement disorders]. Fiziol Cheloveka (1987) 0.75
[Autoantibodies to glutamate receptor subtypes--markers of functional brain damage: their diagnostic significance for detecting paroxysmal activity and ischemia]. Zh Vyssh Nerv Deiat Im I P Pavlova (1997) 0.75
[Neuroimmunopathological mechanisms of preclinical epileptogenesis and their correction by cycloferon]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.75
[Therapeutic and pharmacological monitoring of individual monotherapy of epilepsy with hexamidine]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75
[Neurotropic effect of endogenous peptides having a therapeutic effect on patients with Parkinson's disease]. Dokl Akad Nauk SSSR (1991) 0.75
[The use of the clinical biochemical Epitest kit in children with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75
[Monoclonal antibodies to the glutamate-binding membrane proteins of the human brain are capable of blocking glutamatergic synapses in the spinal cord of the frog Rana ridibunda]. Zh Evol Biokhim Fiziol (1992) 0.75
[Neurochemical Research Society at the Russian Academy of Sciences]. Ross Fiziol Zh Im I M Sechenova (2000) 0.75
[The use of valproates-generics in the treatment of epileptic patients]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.75
[Clinico-electroencephalographic correlations in the process of rehabilitation of patients with epilepsy]. Zh Nevropatol Psikhiatr Im S S Korsakova (1989) 0.75
[Analysis of independent components for event-related potentials from patients with an established diagnosis of schizophrenia, obsessive-compulsive and depressive disorders]. Zh Vyssh Nerv Deiat Im I P Pavlova (2015) 0.75
[Optimisation of epilepsy monotherapy (clinico-pharmacological study)]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75
[Neurochemical aspects of therapeutic electric stimulation]. Fiziol Zh SSSR Im I M Sechenova (1984) 0.75
[The neurophysiological mechanisms in the selection of actions and their disturbance in the attention deficit syndrome]. Fiziol Cheloveka (1999) 0.75
[Laboratory methods in epilepsy and disorders of cerebral circulation]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[Molecular organization of glutamate-sensitive chemoexcitatory membranes of nerve cells. Binding of L-[3H]glutamate to synaptic membranes of the rat cerebral cortex]. Biokhimiia (1984) 0.75
[The pharmacological characteristics, immunochemical identification and study of the location of quisqualate receptors in the rat and human brains]. Zh Evol Biokhim Fiziol (1993) 0.75
[Effect of BCG and cyclophosphamide on the antitumor activity of mouse peritoneal macrophages]. Eksp Onkol (1989) 0.75
[The optimization of epilepsy therapy with finlepsin]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75
[Improving the organization and increasing the quality of the treatment of patients with epilepsy]. Zh Nevropatol Psikhiatr Im S S Korsakova (1990) 0.75
[Glutamate-binding membrane proteins from human platelets]. Biokhimiia (1991) 0.75
[Cloning of cDNA fragment of human brain kainate receptor]. Dokl Akad Nauk SSSR (1989) 0.75
[Use of Fischer's method for analyzing the structure of the glutamate receptors in the central nervous system]. Dokl Akad Nauk SSSR (1984) 0.75
[Experience with the clinical study of the dynamics of severe forms of epilepsy in patients treated by the stereotaxic method]. Zh Nevropatol Psikhiatr Im S S Korsakova (1988) 0.75
[Effect of modifiers of natural biological response on the functional activity of macrophages (oncological aspect)]. Antibiot Khimioter (1990) 0.75
[Effect of endogenous peptides on the status of mediator systems and compensation of motor disorders in parkinsonism]. Fiziol Cheloveka (1995) 0.75
[Immediate results of treating psoriatic arthritis using the hemosorption technic]. Klin Med (Mosk) (1986) 0.75
[Quality of life and rehabilitation of epileptic patients]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75
[Molecular organization of glutamate-sensitive chemoexcitatory membranes of nerve cells. Comparative analysis of glutamate-binding membrane proteins from the cerebral cortex of rats and humans]. Biokhimiia (1987) 0.75
[The clinico-psychological diagnosis of the personality changes in the initial period of epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.75
[Comparative study of the dynamics of ultraslow oscillations per second of biopotentials (zeta waves) and of RNA-synthesizing activity of neuroblastoma and hepatoma cell cultures]. Dokl Akad Nauk SSSR (1983) 0.75
[Interaction of the N- and O-derivatives of aminodicarboxylic acids with CNS glutamate receptors]. Dokl Akad Nauk SSSR (1986) 0.75
[The function of glutamate receptors in the membrane vesicules, proteoliposomes and hybrid cells of the neuroblastoma N18Tg2a]. Fiziol Zh SSSR Im I M Sechenova (1984) 0.75
[Training in communication of medical knowledge]. Sov Zdravookhr (1972) 0.75
[The brain mechanism of error detection: the P.E.T. study]. Ross Fiziol Zh Im I M Sechenova (2011) 0.75
[Autoantibodies against NMDA-receptors in the blood of patients with acute disorders of cerebral circulation]. Vopr Med Khim (2000) 0.75
[Differentiated treatment of epilepsy taking into account the nature of the attacks]. Zh Nevropatol Psikhiatr Im S S Korsakova (1988) 0.75
[Changes in the late positive component of evoked potentials in the GO/NOGO test after cryocingulotomy]. Fiziol Cheloveka (2007) 0.75
[Medico-social aspects of risk factors impairing quality of life in patients with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75
[Some medical-social aspects of the therapy of epilepsy with drugs of new generation: financial side]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[Neuroprotective effects of glycine in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75
[Preclinical epileptogenesis (compensation and prognosis)]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.75